Global X Genomics & Biotechnology ETF
GNOM
64 hedge funds and large institutions have $29.9M invested in Global X Genomics & Biotechnology ETF in 2024 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 5 closing their positions.
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
8% more funds holding
Funds holding: 59 → 64 (+5)
0.52% more ownership
Funds ownership: 7.35% → 7.86% (+0.52%)
3% less capital invested
Capital invested by funds: $31M → $29.9M (-$1.06M)
26% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCM
One Capital Management
Westlake Village,
California
|
+$1.29M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.04M |
| 3 |
Jane Street
New York
|
+$1M |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$702K |
| 5 |
CIBC World Market
Toronto,
Ontario, Canada
|
+$267K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$4.43M |
| 2 |
Lido Advisors
Los Angeles,
California
|
-$1.37M |
| 3 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
-$575K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$264K |
| 5 |
BS
Banco Santander
Madrid,
Spain
|
-$183K |
GNOM Hedge Fund Activity: Q2 2024 in Review
64 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q2 2024, worth a combined $29.9M — down 3.4% from $31M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new GNOM positions and 5 closed out — a net gain of 5 holders — while 14 added to existing stakes and 19 trimmed.
The largest buyer was One Capital Management, adding an estimated $1.29M. The largest seller was Mirae Asset Global Investments, exiting entirely with an estimated $4.43M sold.
- 64 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q2 2024, up from 59 in Q1 2024.
- Funds reported $29.9M of Global X Genomics & Biotechnology ETF stock for Q2 2024, down 3.4% quarter-over-quarter.
- 10 funds opened new Global X Genomics & Biotechnology ETF positions in Q2 2024 and 5 closed out, a net change of +5 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q2 2024 was One Capital Management, an estimated $1.29M added.
- The largest Global X Genomics & Biotechnology ETF seller in Q2 2024 was Mirae Asset Global Investments, an estimated $4.43M sold.
Based on aggregated 13F filings for Q2 2024.